Ozempic For Weight Loss
- All
- News
- Videos
- Web Stories
-
Abbott, Novo Nordisk India Partner Up To Launch Second Brand Of Ozempic, Widen Access To Diabetes Drug
Abbott has entered into a commercialisation agreement with Novo Nordisk India to market a second brand of semaglutide, Extensior, in India
-
8 Tips To Increase GLP-1 Hormone Levels Naturally
Glucagon-like peptide-1 (GLP-1) is a hormone secreted after eating to stimulate insulin release and suppress glucagon, a hormone that raises blood sugar, helping to lower blood sugar.
-
Tanmay Bhat Says He Had No Hunger Suppression While On Weight Loss Drugs; Here's Why
While GLP-1 medications are highly effective for many, an estimated 13% to 25% of users may be considered non-responders who do not experience desired appetite suppression or weight loss.
-
Weight-Loss Drugs Set To Get Cheaper In India As Semaglutide Patents Expire
The cost of popular weight-loss injections like Ozempic and Wegovy is expected to fall in India as patents on semaglutide expire in March 2026, paving the way for generic versions and wider access to anti-obesity medications.
-
Novo Nordisk's CagriSema Delivers 23% Weight Loss In Trial But Still Trails Eli Lilly's Tirzepatide
CagriSema is a once-weekly subcutaneous injection, which is being investigated by Novo Nordisk as a treatment for adults with overweight or obesity.
-
People Continue Taking Ozempic For Weight Loss Despite Side Effects, Reveals Study
The study found that the perceived effectiveness of Ozempic for weight loss is the primary driver of patient satisfaction and intent to continue treatment, even when experiencing side effects.
-
"Lost Hair": Influencer Taking Mounjaro Explains First-Hand Effects Of Weight-Loss Drug
The influencer shared her harrowing experience with the medication and the severe side effects that left her struggling with hair thinning and muscle loss
-
After Aishwarya Mohanraj's 22 Kg Mounjaro Weight Loss Confession, Soha Ali Khan Says, "Takes Great Courage To Speak Truth"
Aishwarya Mohanraj recently made headlines after revealing that she lost 22 kg in six months
-
Novo Nordisk Sues Telehealth Company Over 'Knock-Off' Weight Loss Drugs, Flags Patient Safety Risks
The lawsuit, filed in the US, alleges that Hims infringed Novo Nordisk's patent by mass marketing compounded semaglutide products that have not been cleared by the US Food and Drug Administration (FDA).
-
Just Taking Ozempic Won't Help With Weight Loss, Daily Exercise Still Matters: New Study Warns
A new randomized trial shows that GLP-1 weight-loss drugs like liraglutide help reduce weight but don't improve physical fitness on their own. Structured exercise is essential for meaningful improvements in cardiorespiratory fitness, mobility, and lo
-
Abbott, Novo Nordisk India Partner Up To Launch Second Brand Of Ozempic, Widen Access To Diabetes Drug
Abbott has entered into a commercialisation agreement with Novo Nordisk India to market a second brand of semaglutide, Extensior, in India
-
8 Tips To Increase GLP-1 Hormone Levels Naturally
Glucagon-like peptide-1 (GLP-1) is a hormone secreted after eating to stimulate insulin release and suppress glucagon, a hormone that raises blood sugar, helping to lower blood sugar.
-
Tanmay Bhat Says He Had No Hunger Suppression While On Weight Loss Drugs; Here's Why
While GLP-1 medications are highly effective for many, an estimated 13% to 25% of users may be considered non-responders who do not experience desired appetite suppression or weight loss.
-
Weight-Loss Drugs Set To Get Cheaper In India As Semaglutide Patents Expire
The cost of popular weight-loss injections like Ozempic and Wegovy is expected to fall in India as patents on semaglutide expire in March 2026, paving the way for generic versions and wider access to anti-obesity medications.
-
Novo Nordisk's CagriSema Delivers 23% Weight Loss In Trial But Still Trails Eli Lilly's Tirzepatide
CagriSema is a once-weekly subcutaneous injection, which is being investigated by Novo Nordisk as a treatment for adults with overweight or obesity.
-
People Continue Taking Ozempic For Weight Loss Despite Side Effects, Reveals Study
The study found that the perceived effectiveness of Ozempic for weight loss is the primary driver of patient satisfaction and intent to continue treatment, even when experiencing side effects.
-
"Lost Hair": Influencer Taking Mounjaro Explains First-Hand Effects Of Weight-Loss Drug
The influencer shared her harrowing experience with the medication and the severe side effects that left her struggling with hair thinning and muscle loss
-
After Aishwarya Mohanraj's 22 Kg Mounjaro Weight Loss Confession, Soha Ali Khan Says, "Takes Great Courage To Speak Truth"
Aishwarya Mohanraj recently made headlines after revealing that she lost 22 kg in six months
-
Novo Nordisk Sues Telehealth Company Over 'Knock-Off' Weight Loss Drugs, Flags Patient Safety Risks
The lawsuit, filed in the US, alleges that Hims infringed Novo Nordisk's patent by mass marketing compounded semaglutide products that have not been cleared by the US Food and Drug Administration (FDA).
-
Just Taking Ozempic Won't Help With Weight Loss, Daily Exercise Still Matters: New Study Warns
A new randomized trial shows that GLP-1 weight-loss drugs like liraglutide help reduce weight but don't improve physical fitness on their own. Structured exercise is essential for meaningful improvements in cardiorespiratory fitness, mobility, and lo
